ArticleBMC infectious diseases2025
Prevalence and clinical characteristics of Norwegians who report persistent health complaints attributed to tick bites or tick-borne diseases.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPersistent symptoms attributed to tick bites or tick-borne diseases are poorly understood. We estimate regionally adjusted prevalence of persistent symptoms, investigate seroprevalence (IgG) and ongoing infections, and examine associated demographic and clinical factors.
methodsPersons aged 18 years or older with persistent symptoms lasting six months or more attributed to tick bites or tick-borne diseases, were recruited into a nationwide cross-sectional study. Demographic data were recorded. Medical records were collected (February 2020 - April 2022) and reviewed for tick bites, tick-borne infections, antibiotic treatment, and clinical findings. Outcome measures included somatic symptoms (PHQ-15), fatigue (Fatigue Severity Scale), physical health (RAND-36), and affective symptoms (HAD Scale). Laboratory assessments included polymerase chain reaction (PCR) analysis of blood samples for Borrelia burgdorferi (Bb) and other known tick-borne pathogens, along with IgG antibody detection.
resultsThe highest prevalence of persistent symptoms attributed to tick bites or tick-borne diseases was found in southwestern Norway (0.152-0.155%); the lowest was in the north (0.033%), which also had significantly lower Bb-IgG seroprevalence (15.4% compared to the national average 37.5%). Symptom persistence was not associated with confirmed tick exposure or tick-borne infection. Somatic symptoms were associated with low physical activity and comorbidity. Fatigue and poor physical health were strongly associated with underemployment. Fatigue was also associated with depressive symptoms, low activity, sick leave, and comorbidities.
conclusionsPersistent symptoms were most prevalent in tick-endemic regions but were not associated with prior tick exposure or tick-borne infections. Symptom burden was primarily associated with comorbidities, especially physical inactivity and underemployment. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.